# Elucid Labs AIDA™ - Labelled Image Acquisition Protocol

> **NCT03621462** · NA · UNKNOWN · sponsor: **Elucid Labs Inc.** · enrollment: 4000 (estimated)

## Conditions studied

- Melanoma (Skin)
- Basal Cell Carcinoma of the Skin
- Squamous Cell Carcinoma of the Skin

## Interventions

- **DEVICE:** Artificial Intelligence Dermatology Assistant (AIDA™)

## Key facts

- **NCT ID:** NCT03621462
- **Lead sponsor:** Elucid Labs Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-15
- **Primary completion:** 2020-09-01
- **Final completion:** 2020-10-15
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03621462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03621462, "Elucid Labs AIDA™ - Labelled Image Acquisition Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03621462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*